GRACE :: Lung Cancer

Dr. Ravi Salgia on Management Strategies for Acquired Resistance to Targeted Therapies, Single Focus or More Diffuse

Share
download as a pdf file Download PDF

Dr. Ravi Salgia from University of Chicago explains his approach to management of acquired resistance to a targeted therapy for advanced NSCLC, both in the setting of a single area of progression and also when disease progression is more diffuse.


Leave a Reply

Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share
download as a pdf file Download PDF

GRACE Website Rebuild

Share
download as a pdf file Download PDF

Watch ALK+ Lung Cancer Forum Videos

Share
download as a pdf file Download PDF

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share
download as a pdf file Download PDF

Subscribe to the GRACEcast Podcast on iTunes

Share
download as a pdf file Download PDF

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
(Free Newsletter)

Other Resources

Share
download as a pdf file Download PDF

ClinicalTrials.gov


Biomedical Learning Institute

PeerView Press - Curriculum-Based Learning Activities